Planning for the Payer: Clinical Trial Design Considerations for Today’s Access & Reimbursement Landscape

Life Sciences, Clinical Trials, Pharmaceutical, Healthcare, Commercialization & HEOR, Healthcare Finance,
  • Thursday, April 25, 2024

In today’s pharmaceutical landscape, the value proposition of a drug extends beyond its efficacy for patients and healthcare providers; it also encompasses its impact on payers tasked with managing population health on constrained budgets. Payer consolidation and escalating healthcare costs have underscored the importance of reducing the overall cost of care, making payer considerations essential in clinical trial design.

However, many emerging biotechs focus primarily on scientific innovation, lacking the infrastructure for market access and commercialization expertise. Consequently, trial designs often overlook payer perspectives, jeopardizing successful product commercialization. Ignoring payer considerations not only risks limited access and reimbursement but also potential revenue loss due to unfavorable pricing benchmarks set by key opinion leaders.

In this webinar, experts in market access and clinical development will reveal the results of a survey of payers on their perspectives and priorities, as well as provide deep insights on how companies can navigate this complex landscape and enhance their chances of securing favorable reimbursement.

Register for this webinar today to learn from experts in market access and clinical development about the importance of payer considerations in clinical trial design.


Robert Giannetti, Syneos Health

Robert Giannetti, Vice President, Global Market Access, Syneos Health

Robert Giannetti has 23 years of global market access, pharmaceuticals and vaccine brand marketing, strategic planning, commercial insights generation, and commercial account sales experience. His global expertise spans the full product life cycle from early product development through launch planning and post marketing portfolio management.

Robert leverages technology and innovation to develop strategy and solve problems that drive results, and draws upon his broad background in marketing, sales, analytics, and operations to identify business challenges, develop creative solutions, and build effective teams.

Prior to joining Syneos Health, Robert spent 18 years at Merck in growing market access roles, ultimately leading Global Customer and Brand Insights across Merck’s global vaccine portfolio. He holds a Bachelor’s Degree in Chemical Engineering / Molecular Biology from Penn State, and received his MBA from Leigh University.

Message Presenter
Javier de Renteria, Syneos Health

Javier de Renteria, Market Access Lead EU & Emerging Markets, Syneos Health

Javier de Renteria has more than 25 years of experience in pricing, reimbursement and market access in pharmaceuticals and medical devices (industry and consultancy) at the local, regional and global level in the EU and in emerging markets. He has led more than 1,000 market access research projects with the aim of identifying optimal pricing targets, developing pricing and reimbursement optimal strategies and understanding the necessary data (clinical, economic, real-world evidence) to support price negotiation and renegotiation in oncology, specialty drugs, vaccines, ambulatory and orphan diseases products. Javier is well versed in reimbursement submissions and price negotiations in Europe and has an established relationship with key market access stakeholders at European and at global level.

Before joining Syneos Health, Javier led the Global Market Access EU & Emerging Markets department at Kantar Health.

Message Presenter
Rosa González, Syneos Health

Rosa González, SVP, Head of Product Development Delivery, Syneos Health

Ms. Rosa González has over 29 years of experience in clinical development with special emphasis in immunology, oncology and rare diseases and her experience encompasses the entire drug development continuum. She has worked in CROs and pharmaceutical companies managing global clinical development programs. She also has played key roles in developing strategic partnerships with several pharmaceutical companies.

Ms. González holds a Master of Science in Immunology and had developed her career in the immunology and infectious disease hospital laboratory setting before joining the clinical research industry. She has a Post-degree course in Medicine in the Pharmaceutical Industry and another degree in Pharmaceutical Marketing. Ms. González is a teacher of Master of Monitoring and Medical Affairs and the Post-degree course of Project Management in Clinical Research in CESIF, Universidad San Pablo CEU.

Message Presenter

Nico Schamell, Senior Consultant, Syneos Health

Nico Schamell is a Senior Consultant and has been advising pharmaceutical, biotechnology and medtech companies in the market access arena for more than 5 years.

Nico has managed and supported qualitative and quantitative pricing and market access projects in Europe, Middle East, Asia and Africa. His experience includes project work in cross-functional environments on global, regional and local level, in oncology, immunology and cardiovascular indications and beyond, and ranging from the development of value propositions to the conceptualization and facilitation of multinational advisory boards

Prior to joining the Value & Access team at Syneos Health, Nico worked as a consultant at Executive Insight and Stratas Partners (now PwC) in Switzerland. He started his professional career as an Intern at Novartis in Basel.

Nico holds an MSc in Health Economics from the University of York and a BSc (hons) in Economics with Accounting awarded by City, University of London. His master thesis focuses on the “Cost-effectiveness in Germany: A proposal for the systematic implementation of cost-control measures in the cardio-vascular disease area”.

Message Presenter

Who Should Attend?

This webinar will appeal to the following executives from emerging, small and mid-size biotech companies:

  • Chief Executive Officer
  • Chief Operating Officer
  • Chief Commercial Officer
  • Chief Development Officer
  • Chief Medical Officer
  • Head of Strategy/Operations
  • Head of Market Access

What You Will Learn

In this webinar, the attendees will learn about:

  • The critical role of payers as stakeholders in clinical trial design
  • The key proof points in clinical programs essential for reimbursement success
  • The different approaches to implement strategies that optimize product pricing, secure payer reimbursement and maximize profitability

Xtalks Partner

Syneos Health®

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. They translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Together they share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. They support a diverse, equitable and inclusive culture.

To learn more about how we are shortening the distance from lab to life®, visit or subscribe to our podcast.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account